Sign in
4

Changes in Ownership

Fulgent Genetics, Inc. Filed Acc 0000950170-24-030261

Options or other derivatives

  • Chief Executive Officer disposed of 1,000,000 shares (other)
  • Chief Executive Officer acquired 1,000,000 shares (other)

From the SEC's structured data for this filing

Trades in this filing

Hsieh Ming · Chief Executive Officer

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2024-03-08 Other disposition : show line 1 in the form Forward sale contract (obligation to sell) −1,000,000 0 I
2024-03-08 Other acquisition : show line 2 in the form Forward sale contract (obligation to sell) +1,000,000 1,000,000 I
Loading xslF345X05/ownership.xml…